Patents Assigned to DiaMedica USA Inc.
  • Ulinastatin polypeptides
    Patent number: 11725043
    Abstract: Provided are ulinastatin glycoforms, ulinastatin fusion polypeptides, and related compositions, mixtures, and methods of use, including methods of recombinantly producing ulinastatin polypeptides and treating diseases.
    Type: Grant
    Filed: March 5, 2021
    Date of Patent: August 15, 2023
    Assignee: DiaMedica USA Inc.
    Inventors: Rick Pauls, Todd Verdoorn, Karl Frank Johnson, Gregory Thomas Bleck